Discover open access scientific publications

Search, annotate, share and cite publications

Publications by D. Sibon

Nkp46 Expression Is a Diagnostic and Prognostic Biomarker in Primary Gastrointestinal T-Cell Lymphoproliferations. A Celac Network Study

Hematological Oncology

English

Pooled Results of Three Annual Cohorts From an Observational Prospective Study Describing Brentuximab Vedotin Use in Routine Practice in France for Hodgkin Lymphoma: Interim Analysis

Hematological Oncology

English

Related publications

miR‑150 Is a Negative Independent Prognostic Biomarker for Primary Gastrointestinal Diffuse Large B‑cell Lymphoma

English

ROR2 Is a Novel Prognostic Biomarker and a Potential Therapeutic Target in Leiomyosarcoma and Gastrointestinal Stromal Tumour

English

P037 QSOX1/2 Regulates Lipoprotein [A] Expression and Is a Prognostic Biomarker in Cancer

Journal of Thoracic Oncology

English

Serum miR-26a as a Diagnostic and Prognostic Biomarker in Cholangiocarcinoma

Oncotarget

Oncology

2015

English

Identification of AUNIP as a Candidate Diagnostic and Prognostic Biomarker for Oral Squamous Cell Carcinoma

English

Antibodies Against Human Papillomaviruses as Diagnostic and Prognostic Biomarker in Patients With Neck Squamous Cell Carcinoma From Unknown Primary

International Journal of Cancer

Cancer Research

Oncology

2017

English

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer

Journal of Cancer

Oncology

2017

English

Positive Cyclin T Expression as a Favorable Prognostic Factor in Treating Gastric Gastrointestinal Stromal Tumors

Molecular and Clinical Oncology

Cancer Research

Oncology

2016

English

ERRATUM: Acknowledgments Correction. Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer

Genomics and Informatics

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by D. Sibon

Nkp46 Expression Is a Diagnostic and Prognostic Biomarker in Primary Gastrointestinal T-Cell Lymphoproliferations. A Celac Network Study

Pooled Results of Three Annual Cohorts From an Observational Prospective Study Describing Brentuximab Vedotin Use in Routine Practice in France for Hodgkin Lymphoma: Interim Analysis

Related publications

miR‑150 Is a Negative Independent Prognostic Biomarker for Primary Gastrointestinal Diffuse Large B‑cell Lymphoma

ROR2 Is a Novel Prognostic Biomarker and a Potential Therapeutic Target in Leiomyosarcoma and Gastrointestinal Stromal Tumour

P037 QSOX1/2 Regulates Lipoprotein [A] Expression and Is a Prognostic Biomarker in Cancer

Serum miR-26a as a Diagnostic and Prognostic Biomarker in Cholangiocarcinoma

Identification of AUNIP as a Candidate Diagnostic and Prognostic Biomarker for Oral Squamous Cell Carcinoma

Antibodies Against Human Papillomaviruses as Diagnostic and Prognostic Biomarker in Patients With Neck Squamous Cell Carcinoma From Unknown Primary

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer

Positive Cyclin T Expression as a Favorable Prognostic Factor in Treating Gastric Gastrointestinal Stromal Tumors

ERRATUM: Acknowledgments Correction. Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer